Soru

Zorluk: ZorNormal Pregnancy and Prenatal Care

A 2424-year-old woman, gravida 11, para 00, presents to the clinic at 88 weeks gestation for her initial prenatal visit. Her medical history is unremarkable, and she takes a daily prenatal vitamin. Her blood pressure is 112/70 mmHg112/70\text{ mmHg}, and her body mass index is 22 kg/m222\text{ kg/m}^2. The patient is eager to ensure a healthy pregnancy and asks the physician to outline the standard schedule of recommended screenings and evaluations she will undergo over the coming months.

Arrange the following routine obstetric interventions for this patient in the correct chronological order from earliest to latest gestational age.

  1. 1Routine screening for asymptomatic bacteriuria with a urine culture
  2. 2Measurement of maternal serum pregnancy-associated plasma protein A (PAPP-A) and nuchal translucency
  3. 3Comprehensive transabdominal ultrasound for fetal anatomic survey
  4. 4Administration of a 50-g50\text{-g} oral glucose load followed by a 1-hour1\text{-hour} plasma glucose measurement
  5. 5Collection of a combined vaginal-rectal swab for selective broth media culture

Cevap

The correct chronological sequence is: Urine culture (initial visit), PAPP-A and nuchal translucency (1111-1414 weeks), Anatomic survey ultrasound (1818-2222 weeks), 50-g50\text{-g} oral glucose challenge test (2424-2828 weeks), and Vaginal-rectal swab for Group B Streptococcus (3636-3838 weeks).
Prenatal care follows a chronologic, evidence-based schedule designed to monitor maternal health and fetal development. At the initial visit (usually 88-1010 weeks), routine screening for asymptomatic bacteriuria is performed. Between 1111 and 1414 weeks, first-trimester aneuploidy screening (PAPP-A, free beta-hCG, and nuchal translucency) is offered. In the second trimester (1818-2222 weeks), a comprehensive fetal anatomic survey ultrasound is conducted. Between 2424 and 2828 weeks, patients undergo screening for gestational diabetes mellitus using a 50-g50\text{-g} 1-hour1\text{-hour} oral glucose challenge test. Finally, in the late third trimester (36 0/736\ 0/7 to 37 6/737\ 6/7 weeks), a combined vaginal-rectal swab is collected to screen for Group B Streptococcus (GBS) colonization to determine the need for intrapartum antibiotic prophylaxis.

Adım Adım Çözüm

1
Identify the timing of the urine culture for asymptomatic bacteriuria.
Performed at the initial prenatal visit (first trimester, typically 88-1010 weeks).
Early detection and treatment prevent progression to pyelonephritis.
2
Identify the timing for first-trimester aneuploidy screening.
PAPP-A and nuchal translucency are measured between 1111 and 1414 weeks.
This specific window provides the most accurate risk assessment for trisomies 13, 18, and 21 before the second trimester.
3
Identify the timing for the fetal anatomic survey.
Comprehensive ultrasound is performed between 1818 and 2222 weeks.
Fetal structures are large enough to be clearly visualized, yet early enough to offer reproductive options if severe anomalies are detected.
4
Identify the timing for gestational diabetes screening.
The 50-g50\text{-g} oral glucose challenge test is performed between 2424 and 2828 weeks.
Placental secretion of diabetogenic hormones (e.g., human placental lactogen) peaks late in the second trimester, unmasking insulin resistance.
5
Identify the timing for Group B Streptococcus (GBS) screening.
Vaginal-rectal swab is collected between 3636 and 3838 weeks (specifically 36 0/736\ 0/7 to 37 6/737\ 6/7 weeks).
Screening within 5 weeks of expected delivery provides the highest negative predictive value for intrapartum colonization.

Anahtar Kavram

Routine prenatal care requires a standardized schedule of screenings to optimize maternal and fetal outcomes: initial visit (bacteriuria, standard labs), 1111-1414 weeks (aneuploidy screen), 1818-2222 weeks (anatomy ultrasound), 2424-2828 weeks (gestational diabetes screen), and 3636-3838 weeks (GBS screen).
Bu soruyu puanla